TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE

Objective: To determine the trends of physicians and neurologists in prescribing anti-platelet agents for secondary prevention of non-cardio embolic stroke after 3 months of stroke. Study Design: A descriptive study. Place and Duration of Study: Combined Military Hospital (CMH) Lahore over...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Muhammad Tariq, Faisal Naveed Akhtar, Muhammad Aamir Khan Babar
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2018
Materias:	anti-platelet agents non-cardio embolic stroke Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/f55ed5087e6b422eab8f810dc12a9e11
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:f55ed5087e6b422eab8f810dc12a9e11
record_format	dspace
spelling	oai:doaj.org-article:f55ed5087e6b422eab8f810dc12a9e112021-11-30T02:59:19ZTRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE0030-96482411-8842https://doaj.org/article/f55ed5087e6b422eab8f810dc12a9e112018-12-01T00:00:00Zhttps://www.pafmj.org/index.php/PAFMJ/article/view/2606/2121https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To determine the trends of physicians and neurologists in prescribing anti-platelet agents for secondary prevention of non-cardio embolic stroke after 3 months of stroke. Study Design: A descriptive study. Place and Duration of Study: Combined Military Hospital (CMH) Lahore over a period of four months. Material and Methods: Patients suffering from old (≥3 months) non-cardio embolic stroke, taking anti-platelet agents for secondary prevention and visiting CMH Lahore neurology clinic. Information about their stroke and treatment was obtained from their previous investigations and medical prescriptions. Results: A total of 60 patients met the inclusion criteria of the study; 36 (60%) were taking a combination of clopidogrel 75mg plus Aspirin 75 mg and 12 (20%) received Aspirin 75 mg daily while 12 (20%) were getting other regimens. Conclusion: Combination of clopidogrel 75mg plus Aspirin 75 mg was the most common anti-platelet regimen prescribed for secondary prevention of non-cardio embolic stroke in our study population.Muhammad TariqFaisal Naveed AkhtarMuhammad Aamir Khan BabarArmy Medical College Rawalpindiarticleanti-platelet agentsnon-cardio embolic strokeMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 68, Iss 6, Pp 1744-1748 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	anti-platelet agents non-cardio embolic stroke Medicine R Medicine (General) R5-920
spellingShingle	anti-platelet agents non-cardio embolic stroke Medicine R Medicine (General) R5-920 Muhammad Tariq Faisal Naveed Akhtar Muhammad Aamir Khan Babar TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
description	Objective: To determine the trends of physicians and neurologists in prescribing anti-platelet agents for secondary prevention of non-cardio embolic stroke after 3 months of stroke. Study Design: A descriptive study. Place and Duration of Study: Combined Military Hospital (CMH) Lahore over a period of four months. Material and Methods: Patients suffering from old (≥3 months) non-cardio embolic stroke, taking anti-platelet agents for secondary prevention and visiting CMH Lahore neurology clinic. Information about their stroke and treatment was obtained from their previous investigations and medical prescriptions. Results: A total of 60 patients met the inclusion criteria of the study; 36 (60%) were taking a combination of clopidogrel 75mg plus Aspirin 75 mg and 12 (20%) received Aspirin 75 mg daily while 12 (20%) were getting other regimens. Conclusion: Combination of clopidogrel 75mg plus Aspirin 75 mg was the most common anti-platelet regimen prescribed for secondary prevention of non-cardio embolic stroke in our study population.
format	article
author	Muhammad Tariq Faisal Naveed Akhtar Muhammad Aamir Khan Babar
author_facet	Muhammad Tariq Faisal Naveed Akhtar Muhammad Aamir Khan Babar
author_sort	Muhammad Tariq
title	TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
title_short	TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
title_full	TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
title_fullStr	TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
title_full_unstemmed	TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE
title_sort	trends in prescribing antiplatelet drugs for secondary prevention of non-cardioembolic ischemic stroke
publisher	Army Medical College Rawalpindi
publishDate	2018
url	https://doaj.org/article/f55ed5087e6b422eab8f810dc12a9e11
work_keys_str_mv	AT muhammadtariq trendsinprescribingantiplateletdrugsforsecondarypreventionofnoncardioembolicischemicstroke AT faisalnaveedakhtar trendsinprescribingantiplateletdrugsforsecondarypreventionofnoncardioembolicischemicstroke AT muhammadaamirkhanbabar trendsinprescribingantiplateletdrugsforsecondarypreventionofnoncardioembolicischemicstroke
_version_	1718406899886456832

TRENDS IN PRESCRIBING ANTIPLATELET DRUGS FOR SECONDARY PREVENTION OF NON-CARDIOEMBOLIC ISCHEMIC STROKE

Ejemplares similares